Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q2 23

Dallas, Texas--(Newsfile Corp. - August 30, 2023) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH) for Q2 2023. The full report can be accessed by clicking on the following link: BPTH Q2 23 Report

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

• Prexigebersen reports positive interim results
• $1.7M public offering closed in August
• BP1001-A Phase 1 trials begin

Click image above to view full announcement.

About Stonegate

Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies.

Contacts:

Stonegate Capital Partners
(214) 987-4121
[email protected]

Source: Stonegate, Inc.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/179135

You May Also Be Interested In

• Bee Charged EV Announces Major Funding to Expand Commercial Mobile EV Fleet Charging Operations Nationwide
• Polaris Tech Bridge Announced Companies Selected to Advance to BlueTIDE 2026 Live Demonstration in Newport, RI
• Salzgitter AG acquiring 100 percent of HKM